Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc.

TCMD·NASDAQ

$24.37

-0.16%
HealthcareMedical - Devices

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

At a Glance

Live Snapshot
Market Cap$549.70M
EPS0.8300
P/E Ratio29.36
Earnings Date08/03/2026

tcmd

Revenue

Last Annual Value

329.52M

3-Year CAGR

10%

5-Year CAGR

12%

10-Year CAGR

18%

Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc. Competitors Analysis of Revenue

TCMD · NASDAQ
CompanyRevenue
CAGR 3Y
CAGR 5Y
CAGR 10Y
329.52M
6.3%9.6%14.6% 
SRDX logo
Surmodics, Inc.
NASDAQ:SRDX
126.08M
-1.7%3.7%5.9%
85.23M
245.6%88.8%45.6%
NPCE logo
NeuroPace, Inc.
NASDAQ:NPCE
99.99M
15.2%17.2%N/A
CBLL logo
CeriBell, Inc.
NASDAQ:CBLL
89.06M
25.3%N/AN/A
236.35M
16.7%19.2%20.3%
270.28M
13.9%18.2%24.0%
56.29M
-6.2%1.2%22.4%
97.61M
14.0%9.3%N/A
RXST logo
RxSight, Inc.
NASDAQ:RXST
134.48M
14.7%42.9%N/A
Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc. Fair Value Envelope

TCMD · NASDAQ

Our analysis suggests that TCMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $24.37, this represents a potential HIDDEN relative to our calculated worth for Tactile Systems Technology, Inc..

Intrinsic Value
Current Price: $24.37